Martingale Asset Management L P raised its holdings in Halyard Health, Inc. (NYSE:HYH) by 38.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 98,639 shares of the medical instruments supplier’s stock after purchasing an additional 27,304 shares during the period. Martingale Asset Management L P owned 0.21% of Halyard Health worth $3,875,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Meadow Creek Investment Management LLC grew its stake in Halyard Health by 1.1% during the first quarter. Meadow Creek Investment Management LLC now owns 2,660 shares of the medical instruments supplier’s stock valued at $101,000 after acquiring an additional 28 shares in the last quarter. Glen Harbor Capital Management LLC grew its stake in Halyard Health by 1.1% during the first quarter. Glen Harbor Capital Management LLC now owns 3,230 shares of the medical instruments supplier’s stock valued at $123,000 after acquiring an additional 34 shares in the last quarter. Patten Group Inc. grew its stake in Halyard Health by 0.4% during the first quarter. Patten Group Inc. now owns 19,629 shares of the medical instruments supplier’s stock valued at $769,000 after acquiring an additional 75 shares in the last quarter. Somerset Trust Co grew its stake in Halyard Health by 0.7% during the second quarter. Somerset Trust Co now owns 12,618 shares of the medical instruments supplier’s stock valued at $495,000 after acquiring an additional 90 shares in the last quarter. Finally, State Treasurer State of Michigan grew its stake in Halyard Health by 0.5% during the first quarter. State Treasurer State of Michigan now owns 18,920 shares of the medical instruments supplier’s stock valued at $721,000 after acquiring an additional 100 shares in the last quarter. Hedge funds and other institutional investors own 91.02% of the company’s stock.

Several equities analysts recently commented on the stock. Zacks Investment Research raised shares of Halyard Health from a “hold” rating to a “buy” rating and set a $44.00 price objective for the company in a research note on Wednesday, July 12th. Deutsche Bank AG boosted their price objective on shares of Halyard Health from $35.00 to $42.00 and gave the company a “buy” rating in a research note on Thursday, August 3rd. Stephens raised shares of Halyard Health from an “equal weight” rating to an “overweight” rating in a research note on Thursday, August 3rd. BidaskClub raised shares of Halyard Health from a “hold” rating to a “buy” rating in a research note on Wednesday, June 28th. Finally, TheStreet raised shares of Halyard Health from a “c” rating to a “b” rating in a research note on Thursday, June 22nd. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $42.25.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/09/16/martingale-asset-management-l-p-acquires-27304-shares-of-halyard-health-inc-hyh.html.

Halyard Health, Inc. (HYH) opened at 45.30 on Friday. The company’s 50-day moving average is $43.40 and its 200 day moving average is $39.60. The stock has a market cap of $2.12 billion, a PE ratio of 43.56 and a beta of 1.76. Halyard Health, Inc. has a 52 week low of $31.59 and a 52 week high of $46.36.

Halyard Health (NYSE:HYH) last released its earnings results on Wednesday, August 2nd. The medical instruments supplier reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.14. Halyard Health had a net margin of 3.06% and a return on equity of 8.29%. The company had revenue of $399.20 million for the quarter, compared to analysts’ expectations of $399.16 million. During the same quarter last year, the business earned $0.45 EPS. The firm’s revenue was down .2% compared to the same quarter last year. On average, analysts expect that Halyard Health, Inc. will post $1.98 earnings per share for the current fiscal year.

Halyard Health Profile

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

Receive News & Stock Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related stocks with our FREE daily email newsletter.